References
1. Martin K, Key NS. How I treat patients with inherited bleeding
disorders who need anticoagulant therapy. Blood.2016;128(2):178-184.
2. Dietrich AM, James CD, King DR, Ginn-Pease ME, Cecalupo AJ. Head
trauma in children with congenital coagulation disorders. Journal
of Pediatric Surgery. 1994;29(1):28-32.
3. Klinge J, Auberger K, Auerswald G, et al. Prevalence and outcome of
intracranial haemorrhage in haemophiliacs – a survey of the paediatric
group of the German Society of Thrombosis and Haemostasis (GTH).European Journal of Pediatrics. 1999;158(3):S162-S165.
4. Girolami A, Bertozzi I, de Marinis GB, Tasinato V, Sambado L.
Discrepant ratios of arterial versus venous thrombosis in hemophilia A
as compared with hemophilia B. Journal of Thrombosis and
Thrombolysis. 2014;37(3):293-297.
5. Bokhari R, You E, Bakhaidar M, et al. Dural Venous Sinus Thrombosis
in Patients Presenting with Blunt Traumatic Brain Injuries and Skull
Fractures: A Systematic Review and Meta-Analysis. World
Neurosurg. 2020;142:495-505.e493.
6. Mansour G, Barsky D, Abuhasira S, et al. Traumatic cerebral dural
sinus vein thrombosis/stenosis in pediatric patients—is
anticoagulation necessary? Child’s Nervous System.2021;37(9):2847-2855.
7. Moharir MD, Shroff M, Stephens D, et al. Anticoagulants in pediatric
cerebral sinovenous thrombosis: A safety and outcome study. Annals
of Neurology. 2010;67(5):590-599.
8. van Galen KPM, d’Oiron R, James P, et al. A new hemophilia carrier
nomenclature to define hemophilia in women and girls: Communication from
the SSC of the ISTH. J Thromb Haemost. 2021;19(8):1883-1887.
9. Franchini M. Thrombotic complications in patients with hereditary
bleeding disorders. Thromb Haemost. 2004;92(2):298-304.
10. Stiefel D, Eich G, Sacher P. Posttraumatic dural sinus thrombosis in
children. Eur J Pediatr Surg. 2000;10(1):41-44.
11. Hersh DS, Shimony N, Groves ML, et al. Pediatric cerebral venous
sinus thrombosis or compression in the setting of skull fractures from
blunt head trauma. J Neurosurg Pediatr. 2018;21(3):258-269.
12. Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for
the Management of Hemophilia, 3rd edition. Haemophilia.2020;26(S6):1-158.
13. Girolami A, Tezza F, Scapin M, Vettore S, Casonato A. Arterial and
venous thrombosis in patients with von Willebrand’s disease: a critical
review of the literature. J Thromb Thrombolysis.2006;21(2):175-178.
14. Makris M, Colvin B, Gupta V, Shields ML, Smith MP. Venous thrombosis
following the use of intermediate purity FVIII concentrate to treat
patients with von Willebrand’s disease. Thromb Haemost.2002;88(3):387-388.
15. Franchini M. Thrombotic complications in von Willebrand disease.Hematology. 2006;11(1):49-52.
16. Ruiz-Saez A. Occurrence of thrombosis in rare bleeding disorders.Semin Thromb Hemost. 2013;39(6):684-692.
17. Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, Seligsohn U.
Patients with severe factor XI deficiency have a reduced incidence of
deep-vein thrombosis. Thromb Haemost. 2011;105(2):269-273.
18. Verhamme P, Yi BA, Segers A, et al. Abelacimab for Prevention of
Venous Thromboembolism. New England Journal of Medicine.2021;385(7):609-617.
19. Ichord R. Cerebral Sinovenous Thrombosis. Frontiers in
Pediatrics. 2017;5(163).
20. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic Therapy in
Neonates and Children: Antithrombotic Therapy and Prevention of
Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based
Clinical Practice Guidelines. CHEST. 2012;141(2):e737S-e801S.